Improving the bioactivity of rHirudin with boronophenylalanine site-specific modification

Xin,Xiujuan; Liu,Wenshe; Sun,Liyun

doi:10.3892/mmr.2015.3194

Improving the bioactivity of rHirudin with boronophenylalanine site-specific modification

Authors:
- Xiujuan Xin
- Wenshe Liu
- Liyun Sun
View Affiliations

Affiliations: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, P.R. China, Department of Chemistry, Texas A&M University, College Station, TX 77840, USA
Published online on: January 13, 2015 https://doi.org/10.3892/mmr.2015.3194
Pages: 3774-3779

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

To improve the bioactivity of recombinant (r)Hirudin, the orthogonal pair MjBTyrRS/tRNATyr cua (made up of the boronophenylalanine, tRNA and tRNA synthetase), was selected to incorporate boronophenylalanine site‑specifically into rHirudin at the 63 sites in an Escherichia coli system in response to the TAG codon. Following fusion with the gIII signal peptide and a hexahistidine tag, the modified protein was secreted into Luria‑Bertani culture medium and purified by nickel-nitrilotriacetic acid affinity chromatography following a gel filtration column. In a 200 ml flask, the yield of boronophenylalanine‑modified hirudin was 10 mg l‑1 and that of rHirudin was 19 mg l‑1. The authenticity of the purified proteins was verified using matrix-assisted laser desorption ionization time of flight mass spectroscopy and antithrombin activity assays. The results revealed that the antithrombin activity of the boronophenylalanine‑modified hirudin to human thrombin was more enhanced than that of rHirudin. The modified hirudin demonstrated stronger proliferation inhibiting ability on fibroblast L929 cells compared with that of rHirudin.

View Figures

View References

1	Sohn JH, Kang HA, Rao KJ, Kim CH, et al: Current status of the anticoagulant hirudin: its biotechnological production and clinical practice. Appl Microbiol Biotechnol. 57:606–613. 2001. View Article : Google Scholar
2	Markwardt F: Hirudin as alternative anticoagulant - a historical review. Semin Thromb Hemost. 28:405–414. 2002. View Article : Google Scholar : PubMed/NCBI
3	Stone SR and Hofsteenge J: Kinetics of the inhibition of thrombin by hirudin. Biochemistry. 25:4622–4628. 1986. View Article : Google Scholar : PubMed/NCBI
4	Lee DH, Park JB, Seo JH, et al: Expression of hirudin in fed-batch cultures of recombinant Saccharomyces cerevisiae. Biotechnol Lett. 16:667–670. 1994. View Article : Google Scholar
5	Liu CC, Brustad E, Liu WS and Schultz PG: Crystal Structure of a Biosynthetic sulfo-hirudin complexed to thrombin. J Am Chem Soc. 129:10648–10649. 2007. View Article : Google Scholar : PubMed/NCBI
6	Thurieau C, Simonet S, Paladino J, et al: New N alpha-guanidinobenzoyl derivatives of hirudin-54–65 containing stabilized carboxyl or phosphoryl groups on the side chain of phenylalanine-63. J Med Chem. 37:625–629. 1994. View Article : Google Scholar : PubMed/NCBI
7	Myung J, Kim KB and Crews CM: The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev. 21:245–273. 2001. View Article : Google Scholar : PubMed/NCBI
8	Wang W, Gao X and Wang B: Boronic acid-based sensors for carbohydrates. Curr Org Chem. 6:1285–1317. 2002. View Article : Google Scholar
9	Suzuki A: Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995–1998. J Organomet Chem. 576:147–168. 1999. View Article : Google Scholar
10	Huang SW, Wang B, Shan ZX and Zhao DJ: Asymmetric reduction of acetophenone with borane catalyzed by chiral oxazaborolidinones derived from L-α-amino acids. Synthetic Commun. 30:2423–2429. 2000. View Article : Google Scholar
11	Liu CC and Schultz PG: Recombinant expression of selectively sulfated proteins in Escherichia coli. Nat Biotechnol. 24:1436–1440. 2006. View Article : Google Scholar : PubMed/NCBI
12	Brustad E, Bushey ML, Lee JW, et al: A genetically encoded boronate-containing amino acid. Angew Chem Int Ed Engl. 47:8220–8223. 2008. View Article : Google Scholar : PubMed/NCBI
13	Liu DE, Li X, Zhang GY, Niu ZG, Yi CG, Jia BY, Xia W and Guo SZ: Experimental study on effect of hirudin in inhibiting hyperplastic scar fibroblasts. Zhonghua Shao Shang Za Zhi. 25:265–267. 2009.(In Chinese). PubMed/NCBI
14	Jääger K and Neuman T: Human dermal fibroblasts exhibit delayed adipogenic differentiation compared with mesenchymal stem cells. Stem Cells Dev. 20:1327–1336. 2011. View Article : Google Scholar
15	Zheng L, Baumann U and Reymond JL: An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res. 32:e1152004. View Article : Google Scholar : PubMed/NCBI
16	Schägger H: Tricine-SDS-PAGE. Nat Protoc. 1:16–22. 2006. View Article : Google Scholar
17	Tan S, Wu W, Liu J, et al: Efficient expression and secretion of recombinant hirudin III in E. coli using the L-asparaginase II signal sequence. Protein Expr Purif. 25:430–436. 2002. View Article : Google Scholar : PubMed/NCBI
18	Ferrari M, Fornasiero MC and Isetta AM: MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods. 131:165–172. 1990. View Article : Google Scholar : PubMed/NCBI
19	Lv J, Huang C, Zhang X and Tan S: Extracellular secretion of anticoagulant peptide hirudin in Lactococcus lactis using SP310mut2 signal peptide. Biotechnol Lett. 34:61–65. 2012. View Article : Google Scholar
20	Mohler LK and Czarnik AW: α-Amino acid chelative complexation by an arylboronic acid. J Am Chem Soc. 116:22331994. View Article : Google Scholar
21	Yang W, Gao X and Wang B: Boronic acid compounds as potential pharmaceutical agents. Med Res Rev. 23:346–368. 2003. View Article : Google Scholar : PubMed/NCBI
22	Rydel TJ, Ravichandran KG, Tulinsky A, et al: The structure of a complex of recombinant hirudin and human alpha-thrombin. Science. 249:277–280. 1990. View Article : Google Scholar : PubMed/NCBI
23	Matsui T, Ito C, Oda M, et al: Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars. J Pharm Pharmacol. 63:960–966. 2011. View Article : Google Scholar : PubMed/NCBI